In the 1990s quinolone resistance increased in parallel with increased quinolone utilization (1) and also with the emergence of plasmid-mediated quinolone resistance. The fi rst type of plasmid-mediated resistance was discovered in a clinical strain of Klebsiella pneumoniae isolated at the University of Alabama in 1994 that transferred low-level quinolone resistance along with resistance to several other antibiotics to Escherichia coli and other Gram-negative organisms (2). In E. coli the plasmid caused an eight- to 32-fold decrease in susceptibility for nalidixic acid and for all fl uoroquinolones tested. Although the increased minimum inhibitory concentration (MIC) may remain in the susceptible range as defi ned by the CLSI, the presence of the plasmid raised the mutant protective concentration (3, 4) and facilitated the selection of truly quinolone-resistant mutants (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G. & Quinn, J. P. (2003). Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289, 885–888
MartÃnez-MartÃnez, L., Pascual, A. & Jacoby, G. A. (1998). Quinolone resistance from a transferable plasmid. Lancet 351, 797–799
Jacoby, G. A. (2005). Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl 2, S120–S126
RodrÃguez-MartÃnez, J. M., Velasco, C., GarcÃa, I., Cano, M. E., MartÃnez-MartÃnez, L. & Pascual, A. (2007). Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother 51, 2236–2239
Tran, J. H. & Jacoby, G. A. (2002). Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A 99, 5638–5642
Tran, J. H., Jacoby, G. A. & Hooper, D. C. (2005). Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase I V. Antimicrob Agents Chemother 49, 3050–3052
Tran, J. H., Jacoby, G. A. & Hooper, D. C. (2005). Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49, 118–125
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E. & Blanchard, J. S. (2005). A fluoroqui-nolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science 308, 1480–1403
Nordmann, P. & Poirel, L. (2005). Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 56, 463–469
Robicsek, A., Jacoby, G. A. & Hooper, D. C. (2006). The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6, 629–640
Hata, M., Suzuki, M., Matsumoto, M., Takahashi, M., Sato, K., Ibe, S. & Sakae, K. (2005). Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49, 801–803
Jacoby, G. A., Walsh, K. E., Mills, D. M., Walker, V. J., Oh, H., Robicsek, A. & Hooper, D. C. (2006). qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 50, 1178–1182
Gay, K., Robicsek, A., Strahilevitz, J., Park, C. H., Jacoby, G., Barrett, T. J., Medalla, F., Chiller, T. M. & Hooper, D. C. (2006). Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis 43, 297–304
Stokes, H. W., O'Gorman, D. B., Recchia, G. D., Parsekhian, M. & Hall, R. M. (1997). Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol Microbiol 26, 731–745
Toleman, M. A., Bennett, P. M. & Walsh, T. R. (2006). ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev 70, 296–316
Wang, M., Tran, J. H., Jacoby, G. A., Zhang, Y., Wang, F. & Hooper, D. C. (2003). Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47, 2242–2248
Jeong, J. Y., Yoon, H. J., Kim, E. S., Lee, Y., Choi, S. H., Kim, N. J., Woo, J. H. & Kim, Y. S. (2005). Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother 49, 2522–2524
Paauw, A., Fluit, A. C., Verhoef, J. & Leverstein-van Hall, M. A. (2006). Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital. Emerg Infect Dis 12, 807–812
Garnier, F., Raked, N., Gassama, A., Denis, F. & Ploy, M. C. (2006). Genetic environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica serovar Keurmassar. Antimicrob Agents Chemother 50, 3200–3202
Chen, Y. T., Shu, H. Y., Li, L. H., Liao, T. L., Wu, K. M., Shiau, Y. R., Yan, J. J., Su, I. J., Tsai, S. F. & Lauderdale, T. L. (2006). Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 50, 3861–3866
Poirel, L., Leviandier, C. & Nordmann, P. (2006). Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital. Antimicrob Agents Chemother 50, 3992–3997
Poirel, L., Rodriguez-Martinez, J. M., Mammeri, H., Liard, A. & Nordmann, P. (2005). Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 49, 3523–3525
Cheung, T. K., Chu, Y. W., Chu, M. Y., Ma, C. H., Yung, R. W. & Kam, K. M. (2005). Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J Antimicrob Chemother 56, 586–589
Cattoir, V., Poirel, L., Mazel, D., Soussy, C.-J. & Nordmann, P. (2007). Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob. Agents Chemother. 51, 2650–2651.
Saga, T., Kaku, M., Onodera, Y., Yamachika, S., Sato, K. & Takase, H. (2005). Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli. Antimicrob Agents Chemother 49, 2144–2145
Poirel, L., Liard, A., Rodriguez-Martinez, J. M. & Nordmann, P. (2005). Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J Antimicrob Chemother 56, 1118–1121
Jacoby, G., Chow, N. & Waites, K. (2003). Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 47, 559–562
Strahilevitz, J., Engelstein, D., Adler, A., Temper, V., Moses, A. E., Block, C. & Robicsek, A. (2007). Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob Agents Chemother 51, 3001–3003
Robicsek, A., Strahilevitz, J., Sahm, D. F., Jacoby, G. A. & Hooper, D. C. (2006). qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50, 2872–2874
Corkill, J. E., Anson, J. J. & Hart, C. A. (2005). High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother 56, 1115–1117
Paauw, A., Verhoef, J., Fluit, A. C., Blok, H. E., Hopmans, T. E., Troelstra, A. & Leverstein-van Hall, M. A. (2007). Failure to control an outbreak of qnrA1-positive multidrug-resistant Enterobacter cloacae infection despite adequate implementation of recommended infection control measures. J Clin Microbiol 45, 1420–1425
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Park, C. H., Bush, K. & Hooper, D. C. (2006). Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12, 83–88
Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D. & Hooper, D. C. (2006). Prevalence in the United States of aac(6′)Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50, 3953–3955
Hansen, L. H., Johannesen, E., Burmolle, M., Sorensen, A. H. & Sorensen, S. J. (2004). Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 48, 3332–3337
Hansen, L. H., Jensen, L. B., Sorensen, H. I. & Sorensen, S. J. (2007). Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother 60, 145–147
Périchon, B., Courvalin, P. & Galimand, M. (2007). Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli Antimicrob. Agents Chemother 51, 2464–2469
Yamane, K., Wachino, J., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T. & Arakawa, Y. (2007). New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51, 3354–3360
MartÃnez-MartÃnez, L., Pascual, A., GarcÃa, I., Tran, J. & Jacoby, G. A. (2003). Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 51, 1037–1039
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jacoby, G.A. (2009). Plasmid-Mediated Quinolone Resistance. In: Mayers, D.L. (eds) Antimicrobial Drug Resistance. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-180-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-180-2_17
Publisher Name: Humana Press
Print ISBN: 978-1-60327-592-7
Online ISBN: 978-1-59745-180-2
eBook Packages: MedicineMedicine (R0)